NCLEX Review Guide: Bronchopulmonary Dysplasia

Definition and Development

• Bronchopulmonary dysplasia (BPD) is a chronic lung disease that primarily affects premature infants who have received mechanical ventilation and oxygen therapy for respiratory distress syndrome (RDS). The condition is characterized by inflammation and scarring in the lungs, leading to long-term respiratory problems and oxygen dependency.
• BPD typically develops in premature infants born at less than 28 weeks gestation with birth weights under 1,500 grams who require prolonged mechanical ventilation and oxygen therapy.

Risk Factors

• Prematurity: The earlier the gestational age at birth, the higher the risk of developing BPD due to immature lung development.
• Mechanical ventilation: Positive pressure ventilation can cause barotrauma and volutrauma to the delicate lung tissue of premature infants.
• Oxygen toxicity: Prolonged exposure to high concentrations of oxygen can lead to the formation of oxygen free radicals that damage lung tissue.
• Other factors include: infection, inflammation, fluid overload, patent ductus arteriosus (PDA), genetic predisposition, and nutritional deficiencies.

Signs and Symptoms

• Respiratory distress: Tachypnea (rapid breathing), nasal flaring, intercostal and subcostal retractions, grunting, and cyanosis.
• Oxygen dependency: Continued need for supplemental oxygen beyond 36 weeks postmenstrual age.
• Chronic respiratory symptoms including wheezing, crackles, and decreased air entry on auscultation.
• Poor growth and development due to increased energy expenditure from respiratory effort.

Diagnostic Findings

• Chest radiographs typically show hyperinflation, areas of atelectasis, cystic changes, and a characteristic "bubbly" or "spongy" appearance of the lungs with areas of increased density.
• Blood gases often reveal hypoxemia and hypercapnia (elevated CO₂ levels), indicating impaired gas exchange.
• Pulmonary function tests in older infants show increased airway resistance, decreased compliance, and air trapping.

Respiratory Support

• Oxygen therapy: Supplemental oxygen is provided to maintain oxygen saturation targets (typically 90-95% for BPD infants), balancing the risks of hypoxemia against those of oxygen toxicity.
• Ventilatory support: May range from nasal cannula to continuous positive airway pressure (CPAP) or mechanical ventilation for severe cases. Gentle ventilation strategies with minimal pressures are preferred to prevent further lung injury.

Pharmacological Management

1. Diuretics: Furosemide (Lasix) and thiazide diuretics may be used to reduce pulmonary edema and improve lung compliance. Monitor for electrolyte imbalances, especially hypokalemia and metabolic alkalosis.
2. Bronchodilators: Albuterol or other beta-agonists may help reduce airway resistance in infants with reactive airway components. Assess effectiveness by monitoring respiratory effort and oxygen requirements after administration.
3. Corticosteroids: May be used selectively in severe cases to reduce inflammation and facilitate extubation. Dexamethasone has shown efficacy but carries risks of adverse neurodevelopmental outcomes.
4. Caffeine citrate: Used to treat apnea of prematurity and may have protective effects against BPD development.
5. Vitamin A: Supplementation may reduce BPD incidence by promoting lung repair and protecting against oxidative stress.

Nutritional Support

• Increased caloric needs: Infants with BPD have higher energy expenditure due to increased work of breathing. They typically require 120-150 kcal/kg/day compared to the standard 100-120 kcal/kg/day for healthy preterm infants.
• Fluid restriction: Often necessary to prevent pulmonary edema, requiring higher caloric density feedings to ensure adequate nutrition within fluid limitations.
• Special formulas or breast milk fortifiers with increased caloric density may be used to provide adequate nutrition within fluid restrictions.

Assessment

• Respiratory assessment: Perform comprehensive respiratory assessment every 2-4 hours, including respiratory rate, work of breathing, breath sounds, oxygen saturation, and signs of respiratory distress.
• Growth monitoring: Track weight, length, and head circumference regularly to ensure adequate growth despite increased metabolic demands.
• Monitor for signs of complications such as pulmonary hypertension, cor pulmonale, and systemic hypertension.

Nursing Interventions

• Positioning: Elevate the head of the bed 30-45 degrees to decrease work of breathing and reduce risk of gastroesophageal reflux. Consider prone positioning when monitored to improve oxygenation.
• Respiratory care: Provide chest physiotherapy, suctioning as needed, and ensure proper function of respiratory equipment.
• Infection prevention: Implement strict hand hygiene and infection control measures as infants with BPD are highly susceptible to respiratory infections.
• Developmental care: Minimize environmental stressors, cluster care activities to promote rest, and provide appropriate developmental stimulation.

Discharge Planning and Home Care

• Caregiver education: Provide comprehensive training on oxygen therapy, medication administration, respiratory assessment, and emergency management before discharge.
• Home oxygen therapy: Ensure proper setup of home oxygen equipment and educate caregivers on safe use, storage, and troubleshooting of oxygen delivery systems.
• Immunizations: Ensure the infant is up-to-date on routine immunizations and receives RSV prophylaxis (palivizumab) during RSV season.
• Coordinate follow-up care with multiple specialists, including pulmonology, cardiology, neurodevelopmental, and nutritional services.

Short-term Complications

• Respiratory infections: Infants with BPD are highly susceptible to respiratory infections, which can cause acute deterioration and may require hospitalization.
• Pulmonary hypertension: Develops in approximately 25-40% of infants with moderate to severe BPD due to chronic hypoxemia and abnormal pulmonary vasculature development.
• Growth failure: Increased energy expenditure from respiratory effort combined with feeding difficulties can lead to poor growth.
• Other complications include systemic hypertension, cor pulmonale (right heart failure), and airway malacia (tracheomalacia or bronchomalacia).

Long-term Outcomes

• Reactive airway disease: Many children with a history of BPD develop asthma-like symptoms with airway hyperreactivity persisting into childhood and adolescence.
• Neurodevelopmental impairment: Infants with BPD are at increased risk for developmental delays, cerebral palsy, and cognitive impairments, particularly if they experienced prolonged hypoxemia.
• Exercise intolerance: Decreased lung function and exercise capacity may persist into adulthood, particularly in severe cases.

Prevention Strategies

• Antenatal corticosteroids: Administration to mothers at risk of preterm delivery to accelerate fetal lung maturation.
• Gentle ventilation strategies: Use of volume-targeted ventilation, high-frequency ventilation, and early CPAP to minimize volutrauma and barotrauma.
• Caffeine therapy: Early administration of caffeine citrate to facilitate extubation and reduce apnea of prematurity.
• Vitamin A supplementation: May reduce BPD incidence in extremely low birth weight infants.
• Early extubation to non-invasive respiratory support when possible.

• Bronchopulmonary dysplasia is a chronic lung disease primarily affecting premature infants who require mechanical ventilation and oxygen therapy for respiratory distress syndrome.
• The diagnosis is established when an infant requires oxygen therapy for at least 28 days after birth and continues to have oxygen needs at 36 weeks postmenstrual age.
• Major risk factors include prematurity (especially <28 weeks gestation), mechanical ventilation, oxygen exposure, infection, and inflammation.
• Clinical manifestations include respiratory distress, oxygen dependency, abnormal chest radiographs, and poor growth.
• Management involves respiratory support, medications (diuretics, bronchodilators, corticosteroids), nutritional support, and comprehensive nursing care.
• Complications include respiratory infections, pulmonary hypertension, growth failure, and neurodevelopmental impairment.
• Prevention strategies focus on antenatal corticosteroids, gentle ventilation approaches, and minimizing oxygen exposure.

Self-Assessment Checklist

• I can define BPD and explain its pathophysiology.
• I can identify major risk factors for BPD development.
• I understand the clinical manifestations and diagnostic criteria for BPD.
• I can describe appropriate respiratory management strategies for infants with BPD.
• I know the major medications used in BPD management and their nursing implications.
• I understand the nutritional needs of infants with BPD.
• I can outline important nursing interventions for infants with BPD.
• I am familiar with discharge planning considerations and home care needs.
• I can discuss potential complications and long-term outcomes of BPD.

BPD vs. RDS

BPD vs. Transient Tachypnea of the Newborn (TTN)

Common Pitfalls in BPD Management

Quick Check

Critical Thinking Approach

• When answering NCLEX questions about BPD, remember the ABCs (Airway, Breathing, Circulation) of priority setting. Respiratory status always takes precedence in infants with BPD.
• For medication questions, focus on the nursing implications such as monitoring parameters and side effects rather than just memorizing drug names.
• When presented with a case scenario, look for clues about the severity of BPD (oxygen requirements, ventilator settings) as this will guide your management priorities.

Memory Aids

Focus on Priority Nursing Actions

• For NCLEX questions on BPD, prioritize respiratory assessment and management over other care needs.
• Remember that prevention of infection is critical in BPD care, as respiratory infections can severely worsen the condition.
• Focus on family education for discharge planning questions, particularly regarding home oxygen therapy, medication administration, and signs that require immediate medical attention.